| Literature DB >> 31022261 |
Wietje Nolte1, Georg Thaller2, Christa Kuehn1,3.
Abstract
The study of selection signatures helps to find genomic regions that have been under selective pressure and might host genes or variants that modulate important phenotypes. Such knowledge improves our understanding of how breeding programmes have shaped the genomes of livestock. In this study, 942 stallions were included from four, exemplarily chosen, German warmblood breeds with divergent historical and recent selection focus and different crossbreeding policies: Trakehner (N = 44), Holsteiner (N = 358), Hanoverian (N = 319) and Oldenburger (N = 221). Those breeds are nowadays bred for athletic performance and aptitude for show-jumping, dressage or eventing, with a particular focus of Holsteiner on the first discipline. Blood samples were collected during the health exams of the stallion preselections before licensing and were genotyped with the Illumina EquineSNP50 BeadChip. Autosomal markers were used for a multi-method search for signals of positive selection. Analyses within and across breeds were conducted by using the integrated Haplotype Score (iHS), cross-population Extended Haplotype Homozygosity (xpEHH) and Runs of Homozygosity (ROH). Oldenburger and Hanoverian showed very similar iHS signatures, but breed specificities were detected on multiple chromosomes with the xpEHH. The Trakehner clustered as a distinct group in a principal component analysis and also showed the highest number of ROHs, which reflects their historical bottleneck. Beside breed specific differences, we found shared selection signals in an across breed iHS analysis on chromosomes 1, 4 and 7. After investigation of these iHS signals and shared ROH for potential functional candidate genes and affected pathways including enrichment analyses, we suggest that genes affecting muscle functionality (TPM1, TMOD2-3, MYO5A, MYO5C), energy metabolism and growth (AEBP1, RALGAPA2, IGFBP1, IGFBP3-4), embryonic development (HOXB-complex) and fertility (THEGL, ZPBP1-2, TEX14, ZP1, SUN3 and CFAP61) have been targeted by selection in all breeds. Our findings also indicate selection pressure on KITLG, which is well-documented for influencing pigmentation.Entities:
Mesh:
Year: 2019 PMID: 31022261 PMCID: PMC6483353 DOI: 10.1371/journal.pone.0215913
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Distribution of stallions included in the study by year of birth and breed.
| birth | Trakehner | Holsteiner | Hanoverian | Oldenburger |
|---|---|---|---|---|
| 2002 | 1 | 0 | 0 | 3 |
| 2003 | 0 | 86 | 79 | 60 |
| 2004 | 19 | 90 | 90 | 68 |
| 2005 | 16 | 90 | 70 | 65 |
| 2006 | 8 | 92 | 80 | 25 |
Fig 1Principal Component Analysis (PCA) based on genotype data for four German warmblood horse breeds.
Based on a genomic relationship matrix, eigenvalues were calculated and the first two components used for a colour-coded clustering of the breeds Hanoverian (N = 319), Holsteiner (N = 358), Oldenburger (N = 221), and Trakehner (N = 44).
Overlap of known QTL with selection signatures in four warmblood horse breeds.
| trait | known QTL | overlap selection signatures (iHS | percentage of known QTL |
|---|---|---|---|
| 75 | 1 | 1.3 | |
| 46 | 1 | 2.2 | |
| 8 | 1 | 12.5 | |
| 1 | 1 | 100.0 | |
| 263 | 9 | 3.4 | |
| 7 | 5 | 71.4 | |
| 529 | 16 | 3.0 | |
| 84 | 3 | 3.6 | |
| 115 | 1 | 0.9 | |
| 86 | 3 | 3.5 | |
| 4 | 1 | 25.0 | |
| 78 | 2 | 2.6 |
1 QTL with physical coordinates in base pairs available
2 integrated Haplotype Score selection signature ±1Mb in across breed analysis
3 Run of Homozygosity shared by at least a third of all individuals
4 cross-population Extended haplotype Homozygosity selection signature ±1Mb
Runs of Homozygosity (ROH) shared by at least 33 percent of all individuals (N = 942) across four warmblood horse breeds with candidate genes for positive selection.
| Chr | position (bp) | length of ROH (bp) | SNPs in ROH | samples (%) sharing the entire ROH | annotated genes in ROH | candidate genes | QTL trait (number of QTL) |
|---|---|---|---|---|---|---|---|
| 1 | 684,531–1,346,011 | 661,480 | 20 | 33 | 5 | ||
| 21,937,435–22,763,212 | 825,777 | 20 | 33 | - | |||
| 2 | 96,475,507–97,254,688 | 779,181 | 16 | 33 | 1 | ||
| 100,347,967–100,961,025 | 613,058 | 19 | 35 | 5 | |||
| 3 | 19,390,495–20,068,977 | 678,482 | 20 | 35 | 14 | ||
| 22,774,232–23,723,805 | 949,573 | 24 | 34 | 19 | |||
| 39,317,467–40,650,253 | 1,332,786 | 20 | 34 | 24 | white | ||
| 75,797,341–76,393,636 | 596,295 | 19 | 34 | 13 | THEGL | white (1), | |
| 118,524,879–119,456,949 | 932,070 | 38 | 37 | 18 | MYL5 | ||
| 4 | 15,120,680–17,415,564 | 2,294,884 | 40 | 35 | 24 | IGFBP1, IGFBP3 | |
| 19,079,166–20,235,933 | 1,156,767 | 19 | 40 | 10 | SPATA48, ZPBP | ||
| 52,587,338–53,148,501 | 561,163 | 22 | 36 | 4 | |||
| 5 | 41,546,213–42,335,441 | 789,228 | 24 | 33 | 41 | ||
| 55,293,804–56,274,553 | 980,749 | 28 | 34 | 12 | WNT2B | ||
| 6 | 29,004,794–30,308,246 | 1,303,452 | 28 | 34 | 15 | WNT5B | cannon |
| 34,084,026–35,230,778 | 1,146,752 | 25 | 35 | 51 | |||
| 41,218,272–42,713,648 | 1,495,376 | 25 | 37 | 18 | |||
| 7 | 36,663,831–37,338,232 | 674,401 | 23 | 33 | 6 | ||
| 39,405,488–41,489,510 | 2,084,022 | 47 | 34 | 7 | |||
| 8 | 22,113,249–23,719,695 | 1,606,446 | 32 | 34 | 43 | height (1) | |
| 36,329,323–37,420,192 | 1,090,869 | 20 | 34 | 12 | height (4) | ||
| 9 | 43,718,150–44,540,142 | 821,992 | 20 | 38 | 13 | ||
| 11 | 21,692,258–22,655,280 | 963,022 | 19 | 33 | 35 | KRT complex, IGFBP4, ZPBP2 | hair |
| 24,038,863–24,990,015 | 951,152 | 16 | 38 | 27 | IGF2BP1 | hair (1) | |
| 26,909,643–27,819,093 | 909,450 | 33 | 37 | 4 | |||
| 32,322,500–33,580,784 | 1,258,284 | 29 | 35 | 39 | TEX14 | insect | |
| 15 | 44,286,531–45,105,390 | 818,859 | 16 | 38 | 16 | ||
| 67,528,191–68,378,301 | 850,110 | 18 | 37 | 7 | |||
| 17 | 20,690,428–22,444,884 | 1,754,456 | 28 | 33 | 22 | racing | |
| 18 | 48,042,468–49,758,616 | 1,716,148 | 39 | 36 | 23 | NOSTRIN, MYO3B | racing (1) |
| 58,962,761–59,847,420 | 884,659 | 22 | 34 | 8 | weight | ||
| 22 | 4,359,148–4,944,734 | 585,586 | 15 | 35 | 5 | RALGAPA2 CFAP61 | |
| 15,520,818–16,561,219 | 1,040,401 | 18 | 36 | 6 | BMP2 | ||
| 26,103,882–26,914,845 | 810,963 | 18 | 34 | 20 | GDF5, SPAG4, | ||
| 25 | 26,318,531–26,942,120 | 623,589 | 18 | 43 | 33 | ||
| 28 | 14,158,917–15,080,406 | 921,489 | 19 | 34 | 7 | KITLG | |
| 45,594,055–46,121,975 | 527,920 | 17 | 34 | 29 |
* suspected copy number variation
1 selection signature overlaps with QTL position, data downloaded from AnimalGenome.ORG animal QTL database (accessed 4 February 2019)
2 white markings
3 guttural pouch tympany
4 height of withers
5 cannon bone circumference
6 hair density
7 coat texture
8 insect bite hypersensitivity
9 racing ability
10 body weight
Fig 2Genome-wide integrated Haplotype Score (iHS) plot across four warmblood horse breeds.
Genome-wide iHS plot for all individuals (N = 942) across the four breeds Trakehner, Holsteiner, Hanoverian and Oldenburger with a significance threshold of -log10(p) ≥ 4.0.
Integrated Haplotype Score (iHS) signals across four warmblood horse breeds with a significance threshold of -log10(p-value) ≥ 4.0.
| Chr | SNP position (bp) | iHS | -log10(p-value) | Extended interval of iHS-signals ± 1Mb | annotated genes at iHS-signal ± 1Mb | candidate genes | QTL trait (number of QTL) |
|---|---|---|---|---|---|---|---|
| 1 | 128,778,389 | -3.94 | 4.1 | 127,778,389–129,829,558 | 26 | TPM1, TLN2 | OCD |
| 128,829,558 | -4.04 | 4.26 | |||||
| 1 | 137,759,895 | 4.19 | 4.55 | 136,759,895–140,266,776 | 40 | MYO5A, TMOD2, TMOD3, MYO5C | |
| 138,481,053 | 4.11 | 4.4 | |||||
| 139,162,818 | 4.3 | 4.77 | |||||
| 139,266,776 | 4.16 | 4.5 | |||||
| 4 | 13,965,265 | 3.94 | 4.09 | 12,965,265–21,661,704 | 80 | AEBP1, GCK, DBNL, ZPBP, SUN3, SPATA48, IGFBP1 & 3, MYO1G, MYL7 | |
| 16,091,738 | 3.96 | 4.13 | |||||
| 16,091,813 | 3.96 | 4.13 | |||||
| 17,455,561 | 4.08 | 4.34 | |||||
| 20,661,704 | -4.11 | 4.41 | |||||
| 7 | 39,673,370 | 3.91 | 4.04 | 38,673,370–40,673,370 | 12 | ST14, SNX19 |
1 selection signature overlaps with QTL position, data downloaded from https://www.animalgenome.org/cgi-bin/QTLdb/index (accessed 4 February 2019)
2 osteochondrosis dissecans
Fig 3Breed-specific genome-wide integrated Haplotype Score (iHS) plots within four warmblood horse breeds.
Genome-wide breed-specific iHS plots for Trakehner (A), Holsteiner (B), Hanoverian (C) and Oldenburger (D) with a significance threshold of -log10(p) ≥ 4.0.
Fig 4Cross-population Extended Haplotype Homozygosity (xpEHH) plot for four warmblood horse breeds.
Comparison of one breed with the three others together as control for Trakehner (A), Holsteiner (B), Hanoverian (C)and Oldenburger (D) with a significance threshold of -log10(p) ≥ 4.0.
Cross-population Extended Haplotype Homozygosity (xpEHH)—Comparison of one breed with the other three with a significance threshold of -log10(p) ≥ 4.0.
| breed | Chr | position (bp) | annotated genes at xpEHH-signal ± 1Mb | candidate genes | QTL trait (number of QTL) |
|---|---|---|---|---|---|
| 5 | 18,899,521 | 19 | |||
| 11 | 17,779,157–17,946,985 | 49 | SPATA32, WNT3, MYL4 | height | |
| 51,904,224–51,910,738 | 39 | MYH8, MYH13 | |||
| 18 | 2,187,680–2,187,801 | 17 | MYO7B | height (1) | |
| 37,572,919 | 16 | ||||
| 44,283,029 | 9 | GRB14 | |||
| 21 | 25,682,342–26,310,700 | 27 | |||
| 29,377,724 | 22 | ||||
| 6 | 56,927,881 | 16 | |||
| 7 | 36,118,379–36,156,655 | 9 | height (1) | ||
| 10 | 19,957,969–20,761,246 | 131 | MYH14, MYBPC2 | height (2) | |
| 12 | 20,105,998–20,154,683 | 63 | ZP1 | insect | |
| 1 | 123,021,257–123,023,963 | 11 | |||
| 128,680,555–128,914,146 | 28 | TLN2, TPM1 | OCD | ||
| 7 | 36,103,748–37,353,138 | 19 | height (2) | ||
| 11 | 21,262,535–21,390,555 | 98 | Keratin-complex, IGFBP4 | coat | |
| 12 | 20,138,808–20,154,683 | 63 | ZP1 | insect (1), | |
| 28 | 16,452,599–16,456,910 | 13 | racing | ||
| 3 | 25,755,403 | 16 | |||
| 4 | 13,267,963–14,236,863 | 28 | MYL7, CAMK2B, AEBP1, DBNL | ||
| 6 | 25,827,163 | 31 | GPC1 | ||
| 7 | 53,146,886–53,439,143 | 52 | MTNR1B | gaits | |
| 9 | 17,420,422 | 16 | |||
| 10 | 33,830,402 | 25 | HMGN3 | ||
| 11 | 18,231,316–18,256,680 | 52 | SPATA32, WNT3, MYL4 | height (1) | |
| 15 | 47,471,803–47,772,350 | 5 | tympany | ||
| 16 | 52,972,887–53,092,742 | 15 | |||
| 17 | 16,506,700–16,546,991 | 18 | |||
| 19 | 4,177,482–4,193,516 | 12 | |||
| 52,321,709–53,872,140 | 32 | height (2) | |||
| 22 | 12,955,879–12,956,003 | 12 | |||
| 27,808,920–30,150,639 | 54 | MYL9 |
1 TRAK = Trakehner
2 HOL = Holsteiner
3 HAN = Hanoverian
4 OLD = Oldenburger
5 selection signature overlaps with QTL position, data downloaded from https://www.animalgenome.org/cgi-bin/QTLdb/index (accessed 4 February 2019)
6 height of withers
7 insect bite hypersensitivity
8 osteochondrosis dissecans
9 coat texture
10 hair density
11 racing ability
12 alternate gaits
13 guttural pouch tympany
Fig 5Cross-population Extended Haplotype Homozygosity (xpEHH) plot for Hanoverian versus Oldenburger breed.
Comparison of the two breeds Hanoverian and Oldenburger. Significance threshold -log10(p) ≥ 4.0.
Top 10 enriched pathways determined with DAVID from genes falling in across breed integrated Haplotype Score (iHS) selection signatures in four warmblood horse breeds.
| 23.08 | 9.37E-03 | HECW1, FAM96A, TRIP4, ONECUT1, IKZF1, CSNK1G1, USP3, FIGNL1, PGAM2, RPS27L, STK17A, PSMA2, GABPB1, MAPK6, PPIB, GCK, ZPBP, POLM, LEO1, GNB5, IGFBP3 | 1.77 | 0.65 | |
| 3.30 | 1.35E-02 | MYO5A, MYO1G, MYO5C | 16.67 | 0.74 | |
| 3.30 | 1.39E-02 | MYO5A, MYO1G, MYO5C | 16.42 | 0.55 | |
| 15.38 | 1.47E-02 | MYO5A, UBE2D4, DDX56, MAPK6, CSNK1G1, GCK, FIGNL1, MYO1G, CAMK2B, STK17A, DAPK2, ABCA13, ATP8B4, MYO5C | 2.05 | 0.52 | |
| 3.30 | 1.95E-02 | MYO5A, MYO1G, YKT6 | 13.74 | 1.00 | |
| 4.40 | 2.13E-02 | PSMA2, USP8, USP3, USP50 | 6.68 | 0.97 | |
| 2.20 | 3.02E-02 | IGFBP1, IGFBP3 | 64.45 | 0.64 | |
| 2.20 | 3.02E-02 | IGFBP1, IGFBP3 | 64.45 | 0.64 | |
| 3.30 | 3.39E-02 | MYO5A, DBNL, TLN2 | 10.22 | 0.73 | |
| 2.20 | 4.21E-02 | TMOD2, TMOD3 | 46.04 | 0.65 |
1% = percentage of genes involved in pathway relative to all genes used for analysis
2 p = p-value
3 FE = fold enrichment
4 BH = Benjamini-Hochberg test
Top 10 enriched pathways determined with DAVID from genes falling in across breed Runs of Homozygosity (ROH) selection signatures in four warmblood horse breeds.
| 2.58 | 3.53E-07 | KRT26, KRT25, NES, KRT28, KRT27, KRT12, KRT20, IFFO1, KRT23, KRT24 | 10.32 | 3.69E-05 | |
| 1.80 | 1.04E-04 | HOXB3, HOXB1, HOXB2, HOXB7, HOXB8, HOXB5, HOXB6 | 8.96 | 0.11 | |
| 3.09 | 2.32E-04 | KRT26, KRT25, NES, KRT28, EPB41L1, KRT27, KRT12, LMNA, KRT20, IFFO1, KRT23, KRT24 | 3.93 | 0.06 | |
| 2.06 | 1.41E-03 | HOXB3, HOXB1, HOXB2, HOXB7, HOXB8, HOXB5, HOXB6, NEUROD1 | 4.74 | 0.53 | |
| 8.76 | 1.48E-03 | FASTKD1, MTDH, PNPT1, HDGF, TRMT10A, WBP11, CCT3, MTIF2, POLR2B, MOV10, ARL6IP4, NQO1, FNDC3A, TOP2A, RBM12, RPS27A, ZCCHC8, NIP7, MEX3A, TBRG4, SSB, NOA1, ISG20L2, CASC3, DDX56, DDX55, PPIG, NOP2, EIF4E, HOXB6, POP1, SRP72, RBM39, WDR43 | 1.77 | 0.19 | |
| 0.77 | 5.29E-03 | IGFBP1, IGFBP3, IGFBP4 | 25.35 | 0.40 | |
| 0.77 | 5.29E-03 | IGFBP1, IGFBP3, IGFBP4 | 25.35 | 0.40 | |
| 1.29 | 6.39E-03 | MEF2D, BMP2, WNT5B, GDF5, WNT2B | 6.61 | 0.90 | |
| 1.55 | 1.12E-02 | HOXB3, PTPN6, ARL11, GPATCH4, REST, TOP2A | 4.41 | 0.95 | |
| 0.77 | 1.21E-02 | IGFBP1, IGFBP3, IGFBP4 | 17.01 | 0.93 |
1% = percentage of genes involved in pathway relative to all genes used for analysis
2 p = p-value
3 FE = fold enrichment
4 BH = Benjamini-Hochberg test
Top enriched annotation clusters determined with DAVID from genes falling in across breed integrated Haplotype Score (iHS) and Runs of Homozygosity (ROH) selection signatures in four warmblood horse breeds.
| Term | % | P | Genes | FE | BH | |
|---|---|---|---|---|---|---|
| embryonic skeletal system morphogenesis (GO:0048704) | 1.74 | 2.93E-05 | HOXB3, HOXB1, HOXB2, HOXB7, HOXB8, HOXB5, HOXB6, GLI3 | 8.57 | 0.04 | |
| anterior/posterior pattern specification (GO:0009952) | 1.95 | 8.50E-04 | HOXB3, HOXB1, HOXB2, HOXB7, HOXB8, HOXB5, HOXB6, NEUROD1, GLI3 | 4.46 | 0.42 | |
| transcription factor activity, sequence-specific DNA binding (GO:0003700) | 2.17 | 6.86E-01 | CTBP1, IKZF3, HOXB2, HOXB7, IKZF1, HOXB8, HOXB6, MLXIP, GLI3, SCAND1 | 0.99 | 1.00 | |
| sequence-specific DNA binding (GO:0043565) | 1.30 | 8.36E-01 | HOXB1, HOXB2, HOXB7, ETS1, HOXB6, HOXB13 | 0.85 | 1.00 | |
| IGF II binding (GO:0031995) | 0.65 | 7.67E-03 | IGFBP1, IGFBP3, IGFBP4 | 20.95 | 0.57 | |
| IGF I binding (GO:0031994) | 0.65 | 7.67E-03 | IGFBP1, IGFBP3, IGFBP4 | 20.95 | 0.57 | |
| regulation of IGF receptor signaling pathway (GO:0043567) | 0.65 | 1.71E-02 | IGFBP1, IGFBP3, IGFBP4 | 14.23 | 1.00 | |
| regulation of cell growth (GO:0001558) | 0.87 | 4.61E-02 | CLSTN3, IGFBP1, IGFBP3, IGFBP4 | 4.92 | 1.00 | |
| chondrocyte differentiation (GO:0002062) | 1.30 | 1.82E-03 | SNX19, MEF2D, BMP2, WNT5B, GDF5, WNT2B | 6.64 | 0.54 | |
| cell fate commitment (GO:0045165) | 0.87 | 9.87E-02 | BMP2, WNT5B, ONECUT1, WNT2B | 3.59 | 1.00 | |
| Basal cell carcinoma | 0.87 | 1.20E-01 | BMP2, WNT5B, GLI3, WNT2B | 3.28 | 0.94 | |
| Hippo signaling pathway | 1.08 | 4.74E-01 | BMP2, WNT5B, GDF5, PPP1CB, WNT2B | 1.41 | 0.96 | |
| glycolytic process (GO:0006096) | 0.87 | 2.39E-02 | TPI1, GCK, ENO2, PGAM2 | 6.33 | 0.99 | |
| Glycolysis / Gluconeogenesis | 1.08 | 5.40E-02 | TPI1, GCK, ENO2, PGAM2, G6PC2 | 3.48 | 0.95 | |
| Carbon metabolism | 1.30 | 1.17E-01 | HAO1, TPI1, GCK, ENO2, PGAM2, OGDH | 2.30 | 0.95 | |
| Biosynthesis of antibiotics | 1.74 | 2.29E-01 | HAO1, TPI1, GCK, ENO2, PGAM2, OGDH, PAICS, PPAT | 1.60 | 0.94 | |
| Biosynthesis of amino acids | 0.65 | 5.24E-01 | TPI1, ENO2, PGAM2 | 1.71 | 0.97 |
1% = percentage of genes involved in pathway relative to all genes used for analysis
2 p = p-value
3 FE = fold enrichment
4 BH = Benjamini-Hochberg test
5 ES = enrichment score